These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23719234

  • 1. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D, Agostinho A, Andremont A, Schrenzel J, Pittet D, Harbarth S.
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [Abstract] [Full Text] [Related]

  • 2. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
    Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S, R-Gnosis WP3 study group.
    Clin Microbiol Infect; 2019 Jul; 25(7):830-838. PubMed ID: 30616014
    [Abstract] [Full Text] [Related]

  • 3. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V, Gschliesser T, Grisold A, Zarfel G, Feierl G, Masoud L, Hoenigl M, Resch B, Müller W, Urlesberger B.
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [Abstract] [Full Text] [Related]

  • 4. Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.
    Rieg S, Küpper MF, de With K, Serr A, Bohnert JA, Kern WV.
    BMC Infect Dis; 2015 Oct 28; 15():475. PubMed ID: 26511929
    [Abstract] [Full Text] [Related]

  • 5. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
    Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC.
    Am J Infect Control; 2013 May 28; 41(5):443-7. PubMed ID: 22998785
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.
    Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, Eskira S, Yousef B, Smolykov R, Codish S, Borer A.
    Infect Control Hosp Epidemiol; 2012 Jan 28; 33(1):14-9. PubMed ID: 22173517
    [Abstract] [Full Text] [Related]

  • 7. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    Bar-Yoseph H, Hussein K, Braun E, Paul M.
    J Antimicrob Chemother; 2016 Oct 28; 71(10):2729-39. PubMed ID: 27317444
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities.
    Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, Komalamisra C, Kusolsuk T, Yamamoto Y.
    J Antimicrob Chemother; 2012 Jul 28; 67(7):1769-74. PubMed ID: 22514260
    [Abstract] [Full Text] [Related]

  • 9. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M, Giske CG.
    Clin Microbiol Infect; 2014 Aug 28; 20(8):O508-15. PubMed ID: 24450760
    [Abstract] [Full Text] [Related]

  • 10. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A, Frei R, Adler H, Dangel M, Fux CA, Widmer AF.
    PLoS One; 2015 Aug 28; 10(3):e0120688. PubMed ID: 25803720
    [Abstract] [Full Text] [Related]

  • 11. Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial.
    Ljungquist O, Kampmann C, Resman F, Riesbeck K, Tham J.
    Clin Microbiol Infect; 2020 Apr 28; 26(4):456-462. PubMed ID: 31494254
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.
    Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P.
    Clin Microbiol Infect; 2014 Apr 28; 20(4):350-4. PubMed ID: 23927757
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.
    Dyakova E, Bisnauthsing KN, Querol-Rubiera A, Patel A, Ahanonu C, Tosas Auguet O, Edgeworth JD, Goldenberg SD, Otter JA.
    Clin Microbiol Infect; 2017 Aug 28; 23(8):577.e1-577.e3. PubMed ID: 28242273
    [Abstract] [Full Text] [Related]

  • 15. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
    Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF.
    Clin Infect Dis; 2012 Dec 28; 55(11):1505-11. PubMed ID: 22955436
    [Abstract] [Full Text] [Related]

  • 16. Proportion of rectal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in the inpatients of a pediatric tertiary care hospital in Japan.
    Minami K, Shoji Y, Kasai M, Ogiso Y, Nakamura T, Kawakami Y, Saito Y, Kuzumoto K, Kubota N, Yumoto K, Ishii K.
    Jpn J Infect Dis; 2012 Dec 28; 65(6):548-50. PubMed ID: 23183211
    [Abstract] [Full Text] [Related]

  • 17. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial.
    Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, Raz-Pasteur A, Lavi N, Saad E, Henig I, Horowitz N, Avivi I, Benyamini N, Fineman R, Ofran Y, Haddad N, Rowe JM, Zuckerman T.
    Am J Infect Control; 2013 Dec 28; 41(12):1167-72. PubMed ID: 24274912
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D.
    Infection; 2006 Apr 28; 34(2):66-74. PubMed ID: 16703295
    [Abstract] [Full Text] [Related]

  • 19. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ.
    Int J Infect Dis; 2012 May 28; 16(5):e371-4. PubMed ID: 22401750
    [Abstract] [Full Text] [Related]

  • 20. Rectal Carriage of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Selective Preenrichment Increases Yield of Screening.
    Kluytmans-van den Bergh MF, Verhulst C, Willemsen LE, Verkade E, Bonten MJ, Kluytmans JA.
    J Clin Microbiol; 2015 Aug 28; 53(8):2709-12. PubMed ID: 25994164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.